Silence Therapeutics (SLN) Tax Rate (2024 - 2026)

Silence Therapeutics (SLN) posted Tax Rate of 0.0% for Q3 2025, up 86.95% sequentially from 0.04% in Q2 2025, and up 13.0% YoY from 0.0% in Q3 2024.

Silence Therapeutics (SLN) Tax Rate (2024 - 2026) Analysis & Trends

Silence Therapeutics has reported Tax Rate for 2 years, with the latest figure at 0.0% in Q3 2025.

Quarterly Tax Rate rose 13.0% year-over-year to 0.0% in Q3 2025, while the trailing twelve-month figure through Mar 2026 was 0.01% (down 1603.0% YoY) and the FY2025 annual result came in at 0.01%, down 2501.0% from the prior year.
Tax Rate climbed to 0.0% in Q3 2025 per SLN's latest filing, from 0.04% in the prior quarter.
Over five years, Tax Rate peaked at 0.0% in Q3 2025 and troughed at 92.17% in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Silence Therapeutics	648.22 Mn	576.12 Mn	-	-0.01%

Download Data